Behavioral motor recovery in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned squirrel monkey (Saimiri sciureus): Changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins
- 29 December 2005
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 83 (2) , 332-347
- https://doi.org/10.1002/jnr.20730
Abstract
The neurotoxicant 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) provides an excellent opportunity to study repair and response to injury in the basal ganglia. Administration to mammals leads to the destruction of nigrostriatal dopaminergic neurons and depletion of striatal dopamine. In the squirrel monkey (Saimiri sciureus), MPTP‐lesioning results in parkinsonian motor symptoms including bradykinesia, postural instability, and rigidity. Over time animals display motor behavioral recovery. To better understand this mechanism we employed a lesioning regimen of two or six subcutaneous injections of MPTP (2.0 mg/kg, free‐base) to generate mild or moderate parkinsonism. Brain tissue was harvested at 6 weeks or 9 months after the last injection and analyzed for dopamine and its metabolites by high performance liquid chromatography (HPLC), and by immunohistochemical staining and Western immunoblotting for the expression of tyrosine hydroxylase (TH), dopamine transporter (DAT), and dopamine‐ and cAMP‐responsive protein phosphatase of 32 kDa (DARPP‐32), an effector molecule enriched in striatal medium spiny neurons. Several months after MPTP‐lesioning, when squirrel monkeys displayed full motor behavioral recovery, striatal dopamine levels remained low with a greater return in the ventral striatum. This finding is consistent with other reports using neurotoxicant‐lesioning models of the basal ganglia in rodents and other species of nonhuman primates. Elevated dopamine turnover ratio and decreased DAT expression appeared in early behavioral recovery at the 6‐week time point in both mild‐ and moderate‐parkinsonian monkeys. Tyrosine hydroxylase and DAT expression was increased in late stage recovery even within dopamine‐depleted regions and supports sprouting. Altered DARPP‐32 expression suggests a role of medium spiny neurons in recovery.Keywords
This publication has 61 references indexed in Scilit:
- Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated miceSynapse, 2000
- Regional Differences in Striatal Dopamine Uptake and Release Associated with Recovery from MPTP‐Induced ParkinsonismJournal of Neurochemistry, 1999
- Spontaneous Regeneration of Nigrostriatal Dopaminergic Neurons in MPTP-Treated C57BL/6 MiceBiochemical and Biophysical Research Communications, 1998
- Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neuronsBrain Research, 1991
- MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeysBrain Research, 1990
- Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxinNeuropharmacology, 1989
- Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTPNeuroscience Letters, 1989
- Preservation of dopamine release in the denervated striatumNeuroscience Letters, 1989
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970